Related Experiment Video

Updated: Jan 29, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

Revascularization in Cardiogenic Shock and Advanced Heart Failure

Youssef Rahban1, Carlos D Davila1, Peter S Natov1

  • 1The Cardiovascular Center, Tufts Medical Center, Boston, MA, 02111, USA.

Current Treatment Options in Cardiovascular Medicine
|February 8, 2019
PubMed

Insights

Coronary revascularization may be indicated for advanced heart failure and cardiogenic shock, but evidence is limited. Interventional Heart Failure specialists are crucial for complex revascularization decisions in these high-risk patients.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Ischemic heart disease is a leading cause of heart failure with systolic dysfunction and cardiogenic shock, conditions associated with high mortality.
  • Advanced heart failure is characterized by progressive decline in quality of life and increasing care needs.
  • Cardiogenic shock presents a significant clinical challenge with high mortality rates despite medical advancements.

Purpose of the Study:

  • To review current treatment options for revascularization in patients with ischemic cardiomyopathy, advanced heart failure, and cardiogenic shock.
  • To explore the role of Interventional Heart Failure specialists in the Heart Team approach.
  • To examine available data on revascularization strategies in these complex patient populations.

Main Methods:

  • Review of current literature and clinical guidelines.
  • Analysis of treatment options for coronary revascularization.
  • Exploration of the emerging role of specialized heart failure interventionists.

Main Results:

  • Guideline-directed medical therapy is the primary treatment for advanced heart failure, but coronary revascularization is sometimes necessary.
  • Limited evidence exists for revascularization strategies and mechanical circulatory support in advanced heart failure and cardiogenic shock.
  • Understanding the physiological and hemodynamic impacts of mechanical support is critical before revascularization.
  • Decision-making for revascularization in coronary artery disease with left ventricular dysfunction is complex, requiring interdisciplinary input.
  • Balancing long-term survival benefits against perioperative risks of surgical revascularization is essential.

Conclusions:

  • Coronary revascularization can be considered in select patients with ischemic cardiomyopathy, advanced heart failure, and cardiogenic shock.
  • Further research is needed to establish optimal revascularization strategies and the use of mechanical support in these high-risk groups.
  • The integration of Interventional Heart Failure specialists within the Heart Team is vital for optimizing patient care and outcomes.
Abstract

Keywords:
Cardiogenic shockCoronary artery diseaseHeart failureInterventional heart failure

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.1K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
894
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
865
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
329
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
305